These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34795172)

  • 1. Serum TNF- Related Weak Inducer of Apoptosis (TWEAK), TNF- Related Apoptosis-Inducing Ligand (TRAIL) Levels in Patients with Bipolar Depression, Major Depression and a Healthy Control Group.
    Karadağ H; Saygılı G; Yüksel R; Usta MB; Topçuoğlu C; Erzin G
    Psychiatr Danub; 2021; 33(3):314-319. PubMed ID: 34795172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum TNF-related weak inducer of apoptosis (TWEAK) and TNF-related apoptosis-inducing ligand (TRAIL) levels of patients with bipolar disorder in manic episode, in remission and healthy controls.
    Cingi Yirün M; Yirün O; Ünal K; Yüksel RN; Altunsoy N; Tatlidil Yaylaci E; Aydemir MÇ; Göka E
    Psychiatry Res; 2017 Nov; 257():338-345. PubMed ID: 28800513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Tumor Necrosis Factor (TNF)-Like Weak Inducer of Apoptosis (Tweak) Independently Predicts Subclinical Atherosclerosis in Behcet's Disease.
    Icli A; Cure MC; Cure E; Arslan S; Unal M; Sakiz D; Ozucan M; Toker A; Turkmen K; Kucuk A
    Acta Medica (Hradec Kralove); 2018; 61(3):86-92. PubMed ID: 30543512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Levels of Tumor Necrosis Factor Superfamily Molecules Are Increased in Bipolar Disorder.
    Barbosa IG; Vaz GN; Rocha NP; Machado-Vieira R; Ventura MRD; Huguet RB; Bauer ME; Berk M; Teixeira AL
    Clin Psychopharmacol Neurosci; 2017 Aug; 15(3):269-275. PubMed ID: 28783937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-related weak inducer of apoptosis (TWEAK) levels in schizophrenia.
    Tatlıdil Yaylacı E; Yüksel RN; Ünal K; Altunsoy N; Cingi M; Yalçın Şahiner Ş; Aydemir MÇ; Göka E
    Psychiatry Res; 2015 Oct; 229(3):755-9. PubMed ID: 26275704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the immune-inflammatory profiles of unipolar and bipolar depression.
    Brunoni AR; Supasitthumrong T; Teixeira AL; Vieira EL; Gattaz WF; Benseñor IM; Lotufo PA; Lafer B; Berk M; Carvalho AF; Maes M
    J Affect Disord; 2020 Feb; 262():8-15. PubMed ID: 31693974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder.
    Idemoto K; Ishima T; Niitsu T; Hata T; Yoshida S; Hattori K; Horai T; Otsuka I; Yamamori H; Toda S; Kameno Y; Ota K; Oda Y; Kimura A; Hashimoto T; Mori N; Kikuchi M; Minabe Y; Hashimoto R; Hishimoto A; Nakagome K; Iyo M; Hashimoto K
    J Psychiatr Res; 2021 Feb; 134():48-56. PubMed ID: 33360224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher serum VGF protein levels discriminate bipolar depression from major depressive disorder.
    Chen S; Jiang H; Hou Z; Yue Y; Zhang Y; Zhao F; Xu Z; Li Y; Mou X; Li L; Wang T; Zhao J; Han C; Sui Y; Wang M; Yang Z; Lu Y; Zhu Y; Li J; Shen X; Sun F; Chen Q; Yuan Y
    J Neurosci Res; 2019 May; 97(5):597-606. PubMed ID: 30575991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the difference in time perception between major depressive disorder and bipolar depression through a temporal bisection task.
    Liu P; Guo H; Ma R; Liu S; Wang X; Zhao K; Tan Y; Tan S; Yang F; Wang Z
    PLoS One; 2022; 17(12):e0277076. PubMed ID: 36469514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor superfamily molecules are increased in behavioral variant frontotemporal dementia and correlate with cortical atrophy: An exploratory investigation.
    Vieira ÉLM; Caramelli P; Rocha NP; Freitas Cardoso MDG; de Miranda AS; Teixeira AL; de Souza LC
    J Neuroimmunol; 2021 May; 354():577531. PubMed ID: 33711696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The severity of inflammation in major neuropsychiatric disorders: comparison of neutrophil-lymphocyte and platelet-lymphocyte ratios between schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and obsessive compulsive disorder.
    Bulut NS; Yorguner N; Çarkaxhiu Bulut G
    Nord J Psychiatry; 2021 Nov; 75(8):624-632. PubMed ID: 34319861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
    Mirioglu S; Cinar S; Yazici H; Ozluk Y; Kilicaslan I; Gul A; Ocal L; Inanc M; Artim-Esen B
    Lupus; 2020 Apr; 29(4):379-388. PubMed ID: 32041504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligands and receptors of the TNF superfamily are decreased in major depression and during early antidepressant therapy.
    Schmidt FM; Koch J; Nowak C; Holdt LM; Teupser D; Hegerl U; Himmerich H
    J Psychiatr Res; 2019 Dec; 119():116-121. PubMed ID: 31622870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in serum TNF-like weak inducer of apoptosis (TWEAK) levels and Psoriasis Area Severity Index (PASI) scores in plaque psoriasis patients treated with conventional versus anti-TNF treatments.
    Engin B; Tanakol A; Bulut H; Songür A; Vehid HE; Gökalp E; Kutlubay Z; Özkoca D; Tüzün Y; Serdaroğlu S
    Int J Dermatol; 2020 Feb; 59(2):207-215. PubMed ID: 31531981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State-Dependent Differences in Emotion Regulation Between Unmedicated Bipolar Disorder and Major Depressive Disorder.
    Rive MM; Mocking RJ; Koeter MW; van Wingen G; de Wit SJ; van den Heuvel OA; Veltman DJ; Ruhé HG; Schene AH
    JAMA Psychiatry; 2015 Jul; 72(7):687-96. PubMed ID: 25945779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tumor necrosis factor-like weak inducer of apoptosis levels are elevated in schizophrenia.
    Kiliç F; Işik Ü; Usta A; Demirdaş A
    Braz J Psychiatry; 2021; 43(3):242-246. PubMed ID: 32785454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 as a potential biomarker for differentiating major depressive disorder from bipolar depression.
    Lu L; Hu X; Jin X
    Medicine (Baltimore); 2023 Apr; 102(15):e33439. PubMed ID: 37058046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fn14·TRAIL fusion protein is oligomerized by TWEAK into a superefficient TRAIL analog.
    Prigozhina TB; Szafer F; Aronin A; Tzdaka K; Amsili S; Makdasi E; Shani N; Dranitzki Elhalel M
    Cancer Lett; 2017 Aug; 400():99-109. PubMed ID: 28455246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble TNF-like weak inducer of apoptosis (TWEAK) enhances poly(I:C)-induced RIPK1-mediated necroptosis.
    Anany MA; Kreckel J; Füllsack S; Rosenthal A; Otto C; Siegmund D; Wajant H
    Cell Death Dis; 2018 Oct; 9(11):1084. PubMed ID: 30349023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder.
    Holmes SE; Asch RH; Davis MT; DellaGioia N; Pashankar N; Gallezot JD; Nabulsi N; Matuskey D; Sanacora G; Carson RE; Blumberg HP; Esterlis I
    Biol Psychiatry; 2023 Jun; 93(12):1099-1107. PubMed ID: 36764853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.